Imaging of abdominal and pelvic infections in the cancer patient

被引:7
作者
Itani, Malak [1 ]
Menias, Christine O. [2 ]
Mellnick, Vincent M. [1 ]
El Zakhem, Aline [3 ]
Elsayes, Khaled [4 ]
Katabathina, Venkata [5 ]
Revzin, Margarita V. [6 ]
机构
[1] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA
[2] Mayo Clin, Sch Med, Scottsdale, AZ USA
[3] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Univ Texas Hlth San Antonio, San Antonio, TX USA
[6] Yale Sch Med, New Haven, CT USA
关键词
Infections; Cancer; Abdomen; Pelvis; Gastrointestinal; Genitourinary; HEPATIC-ABSCESS; NEUTROPENIC ENTEROCOLITIS; HEMATOLOGICAL MALIGNANCY; GASTROINTESTINAL-TRACT; VIRUS REACTIVATION; FUNGAL-INFECTIONS; INVASIVE FUNGAL; RISK-FACTORS; DIAGNOSIS; CT;
D O I
10.1007/s00261-020-02896-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Infections are the most commonly encountered complications in patients with cancer. The classical signs and symptoms of infections are often not present in this patient population, which makes the diagnosis more challenging. Host factors play a major role in the development and prognosis of infections in cancer patients; these can be related to the underlying type of malignancy (solid organ versus hematological), tumor burden, anatomic obstruction, altered integrity of barriers (skin or mucosa), treatment-related factors (from chemotherapy, radiation treatment, surgery, interventional procedures, and/or medical device placement) and the degree of immunosuppression. This article reviews common, as well as less common, imaging manifestations of infections and their potential mimics in the abdomen and pelvis in cancer patients and discusses their differentiating features, with the role of imaging in various organs in the abdomen and pelvis taking into consideration relevant clinical background information and the main risk factors.
引用
收藏
页码:2920 / 2941
页数:22
相关论文
共 88 条
[1]   Incidence and Management of Gastrointestinal Perforation from Bevacizumab in Advanced Cancers [J].
Abu-Hejleh, Taher ;
Mezhir, James J. ;
Goodheart, Michael J. ;
Halfdanarson, Thorvardur R. .
CURRENT ONCOLOGY REPORTS, 2012, 14 (04) :277-284
[2]   Diagnosis and treatment of patients with prostatic abscess in the post-antibiotic era [J].
Ackerman, Anne Lenore ;
Parameshwar, Pooja S. ;
Anger, Jennifer T. .
INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (02) :103-110
[3]   Multimodality Imaging of Liver Infections: Differential Diagnosis and Potential Pitfalls [J].
Bachler, Pablo ;
Baladron, Maria Jose ;
Menias, Christine ;
Beddings, Ignacio ;
Loch, Ron ;
Zalaquett, Eugenio ;
Vargas, Matias ;
Connolly, Sarah ;
Bhalla, Sanjeev ;
Huete, Alvaro .
RADIOGRAPHICS, 2016, 36 (04) :1001-1023
[4]   Nephrostomy Tube Related Pyelonephritis in Patients with Cancer: Epidemiology, Infection Rate and Risk Factors [J].
Bahu, Ramez ;
Chaftari, Anne-Marie ;
Hachem, Ray Y. ;
Ahrar, Kamran ;
Shomali, William ;
El Zakhem, Aline ;
Jiang, Ying ;
AlShuaibi, Munirah ;
Raad, Issam I. .
JOURNAL OF UROLOGY, 2013, 189 (01) :130-135
[5]   The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies [J].
Baker, Thomas M. ;
Satlin, Michael J. .
LEUKEMIA & LYMPHOMA, 2016, 57 (10) :2245-2258
[6]   Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview [J].
Blijlevens, NMA ;
Donnelly, JP ;
De Pauw, BE .
BONE MARROW TRANSPLANTATION, 2000, 25 (12) :1269-1278
[7]  
BODEY GP, 1986, ANNU REV MED, V37, P271
[8]  
Buboltz JB., 2020, StatPearls
[9]  
Caldwell Joseph, 2018, Proc (Bayl Univ Med Cent), V31, P297, DOI 10.1080/08998280.2018.1461525
[10]   Microbiology of surgical site infections in patients with cancer: A 7-year review [J].
Carlos Hernaiz-Leonardo, Juan ;
Fernanda Golzarri, Maria ;
Cornejo-Juarez, Patricia ;
Volkow, Patricia ;
Velazquez, Consuelo ;
Ostrosky-Frid, Mauricio ;
Vilar-Compte, Diana .
AMERICAN JOURNAL OF INFECTION CONTROL, 2017, 45 (07) :761-766